{"id":111021,"date":"2024-03-20T08:39:41","date_gmt":"2024-03-20T03:09:41","guid":{"rendered":"http:\/\/finservwealth.com\/trade-spotlight-how-you-should-deal-in-rhi-magnesita-india-rainbow-childrens-medicare-piramal-pharma-today-3\/"},"modified":"2024-03-20T08:39:41","modified_gmt":"2024-03-20T03:09:41","slug":"trade-spotlight-how-you-should-deal-in-rhi-magnesita-india-rainbow-childrens-medicare-piramal-pharma-today-3","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/trade-spotlight-how-you-should-deal-in-rhi-magnesita-india-rainbow-childrens-medicare-piramal-pharma-today-3\/","title":{"rendered":"Trade Spotlight | How you should deal in RHI Magnesita India, Rainbow Childrens Medicare, Piramal Pharma today"},"content":{"rendered":"<p> Piramal Pharma has negated lower highs formation seen in previous 11 consecutive sessions and saw gap up opening on Tuesday. The stock formed bullish candlestick pattern with long upper shadow on the daily charts.<\/p><div id=\"finse-268005387\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/technicals\/trade-spotlight-%7C-how-you-should-dealrhi-magnesita-india-rainbow-childrens-medicare-piramal-pharma-today_17501311.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Piramal Pharma has negated lower highs formation seen in previous 11 consecutive sessions and saw gap up opening on Tuesday. The stock formed bullish candlestick pattern with long upper shadow on the daily charts. Piramal Pharma has negated lower highs formation seen in previous 11 consecutive sessions and saw gap up opening on Tuesday. The stock formed bullish candlestick pattern with long upper shadow on the daily charts.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/technicals\/trade-spotlight-%7C-how-you-should-dealrhi-magnesita-india-rainbow-childrens-medicare-piramal-pharma-today_17501311.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Piramal Pharma has negated lower highs formation seen in previous 11 consecutive sessions and saw gap up opening on Tuesday. The stock formed bullish candlestick pattern with long upper shadow on the daily charts.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/technicals\/trade-spotlight-%7C-how-you-should-dealrhi-magnesita-india-rainbow-childrens-medicare-piramal-pharma-today_17501311.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Piramal Pharma has negated lower highs formation seen in previous 11 consecutive sessions and saw gap up opening on Tuesday. The stock formed bullish candlestick pattern with long upper shadow on the daily charts. Piramal Pharma has negated lower highs formation seen in previous 11 consecutive sessions and saw gap up opening on Tuesday. The stock formed bullish candlestick pattern with long upper shadow on the daily charts.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/technicals\/trade-spotlight-%7C-how-you-should-dealrhi-magnesita-india-rainbow-childrens-medicare-piramal-pharma-today_17501311.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Piramal Pharma has negated lower highs formation seen in previous 11 consecutive sessions and saw gap up opening on Tuesday. The stock formed bullish candlestick pattern with long upper shadow on the daily charts.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-111021","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2024\/200x200\/s\/sensex1_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/111021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=111021"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/111021\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=111021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=111021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=111021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}